These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17006401

  • 1. Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: a randomized clinical trial.
    Sadeghi-Bazargani H, Ehdaeivand F, Arshi S, Eftekhar H, Sezavar H, Amanati L.
    Med Sci Monit; 2006 Oct; 12(10):CR420-5. PubMed ID: 17006401
    [Abstract] [Full Text] [Related]

  • 2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 Jul; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 5. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M, Mukherjee P, Biswas R.
    Int J Fertil; 1980 Jul; 25(2):122-6. PubMed ID: 6117526
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Oral contraceptives: knowledge and compliance].
    Koch T, Marslew U, Nielsen MR.
    Ugeskr Laeger; 1993 Nov 01; 155(44):3546-50. PubMed ID: 8236575
    [Abstract] [Full Text] [Related]

  • 8. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS.
    J SOGC; 1993 Oct 01; 15(8):925-8, 32. PubMed ID: 12318530
    [Abstract] [Full Text] [Related]

  • 9. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.
    Arias RD, Jain JK, Brucker C, Ross D, Ray A.
    Contraception; 2006 Sep 01; 74(3):234-8. PubMed ID: 16904417
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
    Belsey EM.
    Contraception; 1988 Aug 01; 38(2):207-25. PubMed ID: 2971506
    [Abstract] [Full Text] [Related]

  • 12. Use of depo-provera in teens.
    Khoiny FE.
    J Pediatr Health Care; 1996 Aug 01; 10(5):195-201. PubMed ID: 8920351
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q, Jiang H, Fu W.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan 01; 34(1):36-9. PubMed ID: 11263172
    [Abstract] [Full Text] [Related]

  • 15. Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users.
    Chotnopparatpattara P, Taneepanichskul S, Treratanachat S, Charuruks N.
    J Med Assoc Thai; 2003 Feb 01; 86(2):172-7. PubMed ID: 12678156
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Depo provera in perspective.
    McGoldrick IA.
    P N G Med J; 1981 Dec 01; 24(4):274-9. PubMed ID: 6461984
    [Abstract] [Full Text] [Related]

  • 18. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A.
    Fertil Steril; 2006 Feb 01; 85(2):314-25. PubMed ID: 16595206
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.